TAL
BMY.RT

TIG Advisors LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

TIG Advisors LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,226,854
Closed -$2.92M – 472
2020
Q4 		$2.92M Sell
4,226,854
-2,008,162
-32% -$4.28M 0.15% 103
2020
Q3 		$14M Sell
6,235,016
-3,440,010
-36% -$9.82M 0.76% 33
2020
Q2 		$34.6M Sell
9,675,026
-511,491
-5% -$1.85M 3.52% 10
2020
Q1 		$38.7M Buy
10,186,517
+837,977
+9% +$2.76M 1.56% 18
2019
Q4 		$28.1M Buy
+9,348,540
New +$24.3M 1.64% 12

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

TIG Advisors LLC's BMY.RT Position: Q1 2021 in Review

TIG Advisors LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,226,854 shares — an estimated $2.92M sold.

TIG Advisors LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $38.7M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • TIG Advisors LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • TIG Advisors LLC sold 4,226,854 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $2.92M.
  • TIG Advisors LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • TIG Advisors LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $38.7M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on TIG Advisors LLC's 13F filing for Q1 2021, filed 18 May 2021.